The Culprit is Cancer
2 | 3 |
4 | 5 |
6 | 7 |
8 | 9 |
10 | 11 | 12
| 13 | 14
| 15 |
is still hopeful. Other therapies like Herceptin are in early- stage
trials for the treatment of lung, prostate and other cancers. There
are many genetic alterations that might one day be targetable.
the Revlon money brokered for Slamon by Lilly Tartikoff may enable
additional groundbreaking research. Ronald O. Perelman's largesse
is currently funding nutrition studies of breast cancer patients;
enhancing the success of bone marrow transplants; and financing
laboratory studies of a gene known as P53, which is mutated in 50
to 60 percent of women with ovarian cancer.
is also using these resources to educate women about the crucial
value to patients and to medical research of human trials. He's
founded a network of outreach programs in community clinics throughout
really don't believe what made the difference is that we were so
much smarter than anybody else," he says modestly of his team's
success. "But we believed something before anybody else believed
it; we believed that screening tumors for genetic alterations to
develop new therapies was a worthwhile endeavor. A number of my
colleagues thought it wasn't a terribly useful thing to do. But
it paid off.
like to tell you I had all these great insights," says Dennis Slamon,
the man who won a big round in the fight against breast cancer.
"But the science was straightforward and I just believed it would
writer Mona Gable's profile of California Assembly Speaker Antonio
Villaraigosa appeared in the July issue of UCLA Magazine.